— Know what they know.
Not Investment Advice

HEMP OTC

Hemp, Inc
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -99.3% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±2453.1%
$-0 $-0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 48 · $882950 mcap · Short 3% of daily vol

Income Trends

Revenue
$184K +333.7% ▲
5Y CAGR: +11.5%
Gross Profit
$88K +329.6% ▲
5Y CAGR: +4.4%
Operating Income
-$3M +76.1% ▲
Net Income
-$5M +78.4% ▲
EPS (Diluted)
$-0.00 +88.9% ▲
EBITDA
$192K +101.4% ▲
5Y CAGR: +52.4%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
Revenue$2M$2M$3M$43K$184K
YoY Growth+1732.4%+20.0%+7.0%-98.3%+333.7%
Cost of Revenue$101K$2M$1M$22K$97K
Gross Profit$2M$532K$1M$20K$88K
Gross Margin94.8%22.6%51.6%48.1%47.6%
R&D Expenses$0$0$0$0$0
SG&A Expenses$16M$10M$7M$14M$3M
Operating Expenses$16M$10M$7M$14M$3M
Operating Income-$14M-$10M-$5M-$14M-$3M
Operating Margin-722.3%-407.8%-211.3%-32476.4%-1793.1%
Interest Expense$24M$17M$8M$12M$2M
Income Before Tax-$39M-$27M-$13M-$25M-$5M
Tax Expense-$36$0$0$0$0
Net Income-$39M-$27M-$13M-$25M-$5M
Net Margin-1975.6%-1131.2%-511.3%-59636.7%-2973.0%
EPS (Diluted)$-0.01$-0.01$-0.00$-0.00$-0.00
EBITDA-$630K$0$0-$1$192K
Shares Outstanding3.57B5.16B8.24B14.20B23.74B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms